Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus

@article{Safaei2007LovastatinEO,
  title={Lovastatin effects on bone mineral density in postmenopausal women with type 2 diabetes mellitus},
  author={Homan Safaei and Mohsen Janghorbani and Ashraf Aminorroaya and Masoud Amini},
  journal={Acta Diabetologica},
  year={2007},
  volume={44},
  pages={76-82}
}
The objective of this study was to examine the effects of lovastatin on bone mineral density (BMD) of postmenopausal women with type 2 diabetes mellitus (DM). The study was an open-label clinical trial conducted from March 2002 to November 2003. Fifty-five postmenopausal women age 54–67 years with type 2 DM were allocated to lovastatin-treated and control (without lovastatin) groups based on low-density lipoprotein cholesterol (LDL-C) >130 or ≤130 mg/dl. The first group received lovastatin (20… CONTINUE READING
9 Citations
37 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 37 references

Effects of estrogen plus progestin on risk of fracture and bone mineral density : the Women ’ s Health Initiative randomized trial

  • A Cranney, G Wells, +8 authors G Guyatt
  • JAMA
  • 2003

Similar Papers

Loading similar papers…